At the Medicap Pharmacy® stores, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.
New Kidney Cancer Rx May Improve Survival
A new medication could be a game-changer for treating advanced kidney cancer.
Advancing the War Against Advanced Kidney Cancer
Currently, there’s no standard of care to treat kidney cancer that has spread to other parts of the body. A phase ll trial involving an existing drug may change that.
Stomach Cancer Didn't Respond to Rx
Stomach cancer is relatively rare in the US but common in other parts of the world, particularly in Asia. A recent study evaluated the effectiveness of an existing medication in treating this cancer.
Shrinking Brain Tumors and a Whole Lot More
It started out as a drug to combat organ rejection in transplant patients. Everolimus now has many uses, including treating various types of cancer. And the list of its applications is expanding.
FDA Approves Children's Brain Tumor Drug
The US Food and Drug Administration today approved Afinitor Disperz (everolimus tablets for oral suspension), a new pediatric dosage form of the anti-cancer drug Afinitor (everolimus) used to treat a rare brain tumor called subependymal giant cell astrocytoma (SEGA).
Child’s Dosage Approved For Cancer Rx
A rare type of brain tumor called SEGA ( subependymal giant cell astrocytoma ) can appear in children. The drug designed to take on this cancer is too strong for young patients. Now a new children’s dosage of a medication has been approved.
Powerful Rx Combo for Advanced Breast Cancer
The U.S. Food and Drug Administration has approved a drug to be used for postmenopausal women with advanced hormone-receptor positive and HER2-negative breast cancer.
Advancements in Treating Advanced Breast Cancers
A great deal of exciting news has been released recently regarding novel drug combinations that extend the lives of patients living with advanced breast cancers.
FDA approves new treatment for rare type of pancreatic cancer
On Thursday, the U.S. Food and Drug Administration (FDA) approved Afinitor ( everolimus ) to treat patients with progressive neuroendocrine tumors located in the pancreas ( PNET ) that cannot be removed by surgery or that have spread to other parts of the body (metastatic).